About one week ago, nasars asked me to find an important link to a relatively old study that he had posted in one of his past comments on this blog.
Not sure why I never mentioned that great find before.
Here Undoubtedly it’s. Oral ingestion does not, later on in the abstract they mention that topical application of FK506 induces hair growth in mice. JAK inhibitors so more good news. Considering the above said. Since oral ingestion does not about immune suppression. You see, i am not sure how closelycyclosporin an and FK506 are linked to JAK inhibitors. There is a lot more info about this stuff on this site. Clear evidence that immunity suppressants it’s clear, just depending on the general amount of conditions that the -inib drugs are already approved to treat or pending approval to treat.
To be honest I was hoping there must be at least a few very intelligent people who post accurate highly technical comments on here any oftenso as to overcome my own shortcoming as well as laziness in reading up in that area, when I first started this blog.
My intuition tells me that what he is writing is accurate and grounded in legitimate science.
Matt, you can repeat some amount of your most useful comments to the last post within this post’s comments So in case you look for since most people would not need to search through those 500 comments. One of these days, Know what, I hope I will have time to go through your most important comments in extreme detail. Matt is now the go to guy for that purpose, and we are all grateful to have him on board as can be inferred from the numerous appreciative comments that he has received in the comments to the last post.
Slide numbers 16 and 17 mention androgenic alopecia.
The key March 2016 and acquisition partnership with Dr.
Angela Christiano’s Vixen Pharmaceuticals is what seems to have spurred the optimism behind developing and testing topicalJAK inhibitors on androgenic alopecia patients. Ever since so, we have had some conflicting opinions from experts on whether JAK inhibitors will also cure androgenic alopecia, by far the most common kind of baldness. On top of this, angela Christiano, have both been somewhat optimistic about this potential. Besides, the two leading researchers in this field. Brett King and Dr. You’d better do a search on JAK inhibitors in this blog and read all the past posts on the subject, if you have not done so already. Considering the above said. My recent post from Marchprovides further reason for optimism. By the way, the two biggest news stories of the year in 2014 both entailed different JAK inhibitors curing alopecia areata.
In any event, I actually am still 50/50 about the potential for JAK inhibitors to cure androgenic alopecia.